BSE Live
Prev. Close
Open Price
Bid Price (Qty.)
()
Offer Price (Qty.)
()
NSE Live
Jan 16, 15:50Prev. Close
92.71
Open Price
92.71
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
| Balance Sheet of Par Drugs & Chemicals (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| EQUITIES AND LIABILITIES | ||||||
| SHAREHOLDER'S FUNDS | ||||||
| Equity Share Capital | 12.30 | 12.30 | 12.30 | 12.30 | 6.15 | |
| Total Share Capital | 12.30 | 12.30 | 12.30 | 12.30 | 6.15 | |
| Reserves and Surplus | 86.67 | 73.33 | 58.93 | 47.57 | 46.06 | |
| Total Reserves and Surplus | 86.67 | 73.33 | 58.93 | 47.57 | 46.06 | |
| Total Shareholders Funds | 98.97 | 85.63 | 71.24 | 59.88 | 52.21 | |
| NON-CURRENT LIABILITIES | ||||||
| Long Term Borrowings | 0.00 | 0.00 | 0.00 | 0.00 | 4.39 | |
| Deferred Tax Liabilities [Net] | 3.58 | 3.54 | 3.50 | 3.55 | 3.41 | |
| Other Long Term Liabilities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Long Term Provisions | 0.27 | 0.00 | 0.14 | 0.41 | 0.39 | |
| Total Non-Current Liabilities | 3.85 | 3.54 | 3.64 | 3.96 | 8.19 | |
| CURRENT LIABILITIES | ||||||
| Short Term Borrowings | 0.00 | 0.00 | 0.00 | 0.00 | 3.25 | |
| Trade Payables | 10.89 | 5.36 | 8.09 | 10.66 | 6.72 | |
| Other Current Liabilities | 1.10 | 1.94 | 1.98 | 0.80 | 2.46 | |
| Short Term Provisions | 4.58 | 5.14 | 3.92 | 3.40 | 3.55 | |
| Total Current Liabilities | 16.57 | 12.44 | 13.99 | 14.86 | 15.98 | |
| Total Capital And Liabilities | 119.39 | 101.61 | 88.87 | 78.69 | 76.38 | |
| ASSETS | ||||||
| NON-CURRENT ASSETS | ||||||
| Tangible Assets | 38.91 | 41.31 | 38.45 | 34.10 | 29.91 | |
| Intangible Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Capital Work-In-Progress | 0.00 | 0.03 | 0.25 | 0.25 | 4.52 | |
| Other Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Fixed Assets | 38.91 | 41.33 | 38.69 | 34.35 | 34.43 | |
| Non-Current Investments | 25.07 | 0.01 | 0.01 | 0.01 | 0.01 | |
| Deferred Tax Assets [Net] | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Long Term Loans And Advances | 0.00 | 0.00 | 0.00 | 0.00 | 0.76 | |
| Other Non-Current Assets | 0.54 | 0.64 | 0.73 | 0.76 | 0.00 | |
| Total Non-Current Assets | 64.53 | 41.99 | 39.43 | 35.13 | 35.20 | |
| CURRENT ASSETS | ||||||
| Current Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Inventories | 6.11 | 4.18 | 5.38 | 4.71 | 3.00 | |
| Trade Receivables | 16.71 | 13.71 | 16.97 | 18.47 | 12.45 | |
| Cash And Cash Equivalents | 27.58 | 36.65 | 22.24 | 16.21 | 21.16 | |
| Short Term Loans And Advances | 0.10 | 0.09 | 0.08 | 0.05 | 0.92 | |
| OtherCurrentAssets | 4.36 | 4.98 | 4.77 | 4.13 | 3.65 | |
| Total Current Assets | 54.86 | 59.62 | 49.44 | 43.56 | 41.19 | |
| Total Assets | 119.39 | 101.61 | 88.87 | 78.69 | 76.38 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| CONTINGENT LIABILITIES, COMMITMENTS | ||||||
| Contingent Liabilities | 0.10 | 0.10 | 0.00 | 0.00 | 0.24 | |
| CIF VALUE OF IMPORTS | ||||||
| Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Stores, Spares And Loose Tools | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Trade/Other Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Capital Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| EXPENDITURE IN FOREIGN EXCHANGE | ||||||
| Expenditure In Foreign Currency | 0.19 | 4.66 | 3.08 | 1.46 | 0.94 | |
| REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS | ||||||
| Dividend Remittance In Foreign Currency | -- | -- | -- | -- | -- | |
| EARNINGS IN FOREIGN EXCHANGE | ||||||
| FOB Value Of Goods | 25.32 | 23.29 | 19.98 | 17.93 | 9.71 | |
| Other Earnings | -- | -- | -- | -- | -- | |
| BONUS DETAILS | ||||||
| Bonus Equity Share Capital | -- | -- | -- | -- | -- | |
| NON-CURRENT INVESTMENTS | ||||||
| Non-Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
| Non-Current Investments Unquoted Book Value | -- | -- | -- | -- | -- | |
| CURRENT INVESTMENTS | ||||||
| Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
| Current Investments Unquoted Book Value | -- | -- | -- | -- | -- |
27.11.2025
Par Drugs Standalone September 2025 Net Sales at Rs 28.66 crore, down 17.31% Y-o-Y
22.08.2025
Par Drugs Standalone June 2025 Net Sales at Rs 26.05 crore, up 15.22% Y-o-Y
12.05.2025
Par Drugs Standalone March 2025 Net Sales at Rs 22.33 crore, down 2.14% Y-o-Y
23.10.2024
Par Drugs Standalone September 2024 Net Sales at Rs 34.66 crore, up 33.88% Y-o-Y
15.03.2018
24.04.2017
24.04.2017
20.04.2017